Health
Antimicrobials, Antibiotics & Drug Resistances
Bacteria & Other Microorganisms
Post-Doctoral Fellowships
France
Pharmacodiversity Oriented Synthesis: A New Tool For The Rapid Discovery Of Treatment For Multidrug-Resistant Bacteria
The threat posed by drug-resistant bacteria and other microbes is increasing as new strains emerge. Yet, major pharmaceutical companies are not seeking new drugs to fight back. Dr. Andrew Silvanus is developing a faster, easier method of screening candidates for potential new “superdrugs”: starting with natural substances containing molecular structures already known to fight infection, tweaking them in a variety of ways, and testing the results. Silvanus's work has the potential to accelerate vital antibiotic discovery.
Antibiotic Resistance: Finding New Drugs Faster
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Andrew Christopher
SILVANUS
Institution
Université de Versailles Saint-Quentin-en-Yvelines
Country
France
Nationality
British
Related articles
Health
Medical Treatment & Drug Development
Antimicrobials, Antibiotics & Drug Resistances
Bacteria & Other Microorganisms
Drug Delivery
Mécénat des Mutuelle
France
New Molecule to Combat Antibiotic-Resistant Childhood Sepsis
The global spread of antibiotic resistance requires the identification of new bacterial drug targets, the design and synthesis of innovative... Read more
Nalini
RAMA RAO
